AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+33.49%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.83B
AUM Growth
+$3.83B
Cap. Flow
-$4.23B
Cap. Flow %
-110.43%
Top 10 Hldgs %
84.96%
Holding
115
New
10
Increased
27
Reduced
10
Closed
11

Top Buys

1
SRRK icon
Scholar Rock
SRRK
$37.4M
2
LXRX icon
Lexicon Pharmaceuticals
LXRX
$23.6M
3
BPMC
Blueprint Medicines
BPMC
$15.9M
4
AUTL
Autolus Therapeutics
AUTL
$14.1M
5
ZGNX
Zogenix, Inc.
ZGNX
$13.3M

Top Sells

1
BUFF
Blue Buffalo Pet Products, Inc
BUFF
$3.48B
2
WW
WW International
WW
$872M
3
INCY icon
Incyte
INCY
$25M
4
AVXS
AveXis, Inc. Common Stock
AVXS
$19.8M
5
AGIO icon
Agios Pharmaceuticals
AGIO
$12.6M

Sector Composition

1 Consumer Discretionary 54.99%
2 Healthcare 44.37%
3 Energy 0%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRWD icon
51
Ironwood Pharmaceuticals
IRWD
$214M
$4.15M 0.09% 216,879 – –
CBIO
52
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$4.03M 0.09% 250,000 -75,000 -23% -$1.21M
SYBX icon
53
Synlogic
SYBX
$17M
$3.93M 0.08% 400,000 – –
KDNY
54
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3.85M 0.08% 550,000 – –
WVE icon
55
Wave Life Sciences
WVE
$1.53B
$3.83M 0.08% 100,000 -50,000 -33% -$1.91M
RCUS icon
56
Arcus Biosciences
RCUS
$1.13B
$3.67M 0.08% 300,000 – –
ACGN
57
DELISTED
Aceragen, Inc. Common Stock
ACGN
$3.63M 0.08% 2,750,000 – –
TECX
58
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$3.57M 0.08% +125,000 New +$3.57M
MRNS
59
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.54M 0.08% 500,000 – –
VRDN icon
60
Viridian Therapeutics
VRDN
$1.5B
$3.21M 0.07% 500,000 – –
UBX
61
DELISTED
Unity Biotechnology
UBX
$3.01M 0.06% +200,000 New +$3.01M
TCDA
62
DELISTED
Tricida, Inc. Common Stock
TCDA
$2.99M 0.06% +100,000 New +$2.99M
CRSP icon
63
CRISPR Therapeutics
CRSP
$4.71B
$2.94M 0.06% 50,000 +25,000 +100% +$1.47M
SGMO icon
64
Sangamo Therapeutics
SGMO
$157M
$2.84M 0.06% 200,000 +50,000 +33% +$710K
DNTH icon
65
Dianthus Therapeutics
DNTH
$759M
$2.7M 0.06% +200,000 New +$2.7M
CMTA
66
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$2.63M 0.06% 200,000 – –
NTLA icon
67
Intellia Therapeutics
NTLA
$1.22B
$2.46M 0.05% 90,000 – –
CMRX
68
DELISTED
Chimerix, Inc.
CMRX
$2.38M 0.05% 500,000 – –
KRYS icon
69
Krystal Biotech
KRYS
$4.27B
$2.23M 0.05% 150,000 – –
ADVM icon
70
Adverum Biotechnologies
ADVM
$64.6M
$2.12M 0.05% 400,000 – –
QTTB icon
71
Q32 Bio
QTTB
$20.9M
$2.04M 0.04% 100,000 – –
KNSA icon
72
Kiniksa Pharmaceuticals
KNSA
$2.48B
$1.74M 0.04% +100,000 New +$1.74M
SNNA
73
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$1.5M 0.03% +99,000 New +$1.5M
XENE icon
74
Xenon Pharmaceuticals
XENE
$2.98B
$1.38M 0.03% 150,000 – –
NVLN
75
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$944K 0.02% 256,400 – –
1 2
3
4 5